PMC:7544934 / 1580-1779
Annnotations
LitCovid_Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 42-45 | https://glytoucan.org/Structures/Glycans/G00057MO | denotes | LDN |
| T4 | 42-45 | https://glytoucan.org/Structures/Glycans/G31736BK | denotes | LDN |
| T5 | 92-95 | https://glytoucan.org/Structures/Glycans/G00057MO | denotes | LDN |
| T6 | 92-95 | https://glytoucan.org/Structures/Glycans/G31736BK | denotes | LDN |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 38 | 77-81 | Gene | denotes | ACE2 | Gene:59272 |
| 54 | 173-194 | Disease | denotes | coronavirus infection | MESH:D018352 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T17 | 92-195 | Sentence | denotes | LDN may be considered as a target as the treatment and (or) adjuvant therapy for coronavirus infection. |